WHO ICTRP trial
The Effect of Pancreatic stone protein/Regenerating protein Ia(PSP/Reg Ia) in…
ChiCTR2300072247 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300072247 |
|---|---|
| Public title | The Effect of Pancreatic stone protein/Regenerating protein Ia(PSP/Reg Ia) in Kidney Function Decrease |
| Scientific title | The Effect of Pancreatic stone protein/Regenerating protein Ia(PSP/Reg Ia) in Kidney Function Decrease |
| Primary sponsor | Zhongda Hospital Southeast University, Hunanlu Business District, Nanjing City, Jiangsu Province |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | CHINA |
| Conditions | Chronic kidney disease |
| Interventions | CKD:none;T2DM:none;Healthy control group:none |
| Registration date | Jun 7, 2023 |
| Target size | CKD:500;T2DM:500;Healthy control group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: